
Overview
Clininote is a platform that facilitates the collection of structured clinical data for clinical trials and Real-World Evidence (RWE), enhancing efficiency within electronic health records (EHR). It provides tools for creating and managing customizable templates, automating data entry, and generating reports to streamline clinical documentation. Additionally, Clininote supports real-time data accuracy and compliance by detecting errors early in the research process.
Financials
Revenue history (in k)
From the notes
| Profit allocation | Loss to be covered | |
| Loans and borrowings | $197,214 | |
| Foreign sales | 100% of revenue ($10,489) | |
| Related parties | 2 items |
Filing timeliness
Financial statements were filed on time, on average 55 days early.
- 202501/06/2026
- 202406/07/2025
- 202330/06/2024
- 202201/06/2023
- 202101/07/2022
- 202026/03/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Clinical documentation software
- Medical note templates
- Clinical data collection
- Medical data validation
- Analytical reports
- Clinical trial software
Websites
The site is available in: Polish and English. The site targets these markets: United States.
- clininote.comCliniNote – uwolnij potencjał danych klinicznychWordPress 7.1ElementorGoogle AnalyticsGoogle Tag ManagerMatomoApache
Public procurement
1 tender recorded as contractor, with a total value of $64,457.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| May 11, 2026 | Supply, installation, configuration, implementation and production launch of the Physician Assistant System for creating medical notes, and provision of warranty services | $64,457$64,457 | Uniwersytet Medyczny w Białymstoku |
Authorized Representatives
Manner of representation
If the management board consists of 1 (one) person, the sole member of the management board is authorised to represent the company independently. If the management board consists of 2 (two) or more members of the management board, the company is represented as follows: (I) if no Vice-President of the Management Board for Finance has been appointed, each member of the management board is authorised to make declarations and sign documents on behalf of the company independently; (II) if a Vice-President of the Management Board for Finance has been appointed, the representation of the company in every case requires the joint action of 2 (two) members of the management board, always together with that Vice-President of the Management Board for Finance.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Robert Ługowski age 51 | 400 | $5,402.49 | 39.604% |
Jan Tadeusz Poleszczuk age 40 | 200 | $2,701.24 | 19.802% |
Sunfish Poland i Gmbh & Co. Kg | 146 | $1,971.91 | 14.4554% |
Rafał Jan Szmuc age 56 | 200 | $2,701.24 | 19.802% |
Kacper Marzoch age 45 | 11 | $148.57 | 1.0891% |
Paweł Mańdok | 10 | $135.06 | 0.9901% |
Piotr Ruciński age 53 | 10 | $135.06 | 0.9901% |
Sławomir Szymankiewicz age 56 | 10 | $135.06 | 0.9901% |
| 9 | $121.56 | 0.8911% | |
Katarzyna Pieniądz age 45 | 6 | $81.04 | 0.5941% |
Paweł Woźniak age 46 | 5 | $67.53 | 0.495% |
Katarzyna Wyciszkiewicz age 54 | 3 | $40.52 | 0.297% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Sunfish Poland I GmbH & Co. KG (Germany) group, which is its direct owner.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 28, 2023 | Aid for SME access to finance — risk finance aid | $941.3K$941,253 | PFR Ventures sp. z o.o. | |
| Sep 23, 2021 | Aid for SME access to finance — aid for start-ups | $251.9K$251,873 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Aug 5, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $7,171$7,171 | Puławski Park Naukowo - Technologiczny sp. z o.o. |
European Funds
5 projects recorded: 1 from FE lists ($251,873) and 4 Commission grants (FTS) ($297,667).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2023-11-01 | Digital infrastructure for oncology in europe | $37,840$37,840 | 2.1.11 - European Regional Development Fund (ERDF) | |
| 2022-09-01 | Intelligent ecosystem to improve the governance, the sharing and the re-use of health data for rare cancers | $125.6K$125,575 | 1.0.11 - Horizon Europe | |
| 2022-09-01 | Intelligent ecosystem to improve the governance, the sharing and the re-use of health data for rare cancers | $121.3K$121,261 | 1.0.11 - Horizon Europe |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Comarch Telemedicine sp. z o.o. | $57,114.87 | comarch-telemedicine.com | ||
| Idocly sp. z o.o. | $49,591.94 | hicora.ai | ||
| Revolet sp. z o.o. | $44,920.23 | revolet.com | ||
| Terapia Plus sp. z o.o. | $40,180.80 | terapia-plus.pl | ||
| Veterinaro sp. z o.o. | $34,906.17 | veterinaro.pl | ||
| PRP Analytics sp. z o.o. | $19,330.11 | prpanalytics.eu | ||
| Fabryka w Chmurach sp. z o.o. | $18,317.41 | systemrcp.pl | ||
| H2M sp. z o.o. | $10,462.09 | pozyskajpacjenta.pl | ||
| Ezdrowie Pro sp. z o.o. | $8,036.23 | ezdrowiepro.pl | ||
| Konkludi Med P.S.A. | $3,929.88 | ikzocr.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-21 | Share capital increase (46,650.00 PLN → 50,500.00 PLN) | |
| 2023-09-29 | Share capital increase (40,000.00 PLN → 46,650.00 PLN) | |
| 2023-09-29 | PKD change (Added: 72.19.Z) | |
| 2023-07-26 | Share capital increase (10,000.00 PLN → 40,000.00 PLN) | |
| 2020-12-04 | Name change (Mednote → Clininote) |
FAQ
Last updated: 2026-06-01
